Loading…
Declining tuberculosis case notification rates with the scale-up of antiretroviral therapy in Zimbabwe
Setting: Zimbabwe has a human immunodeficiency virus (HIV) driven tuberculosis (TB) epidemic, with antiretroviral therapy (ART) scaled up in the public sector since 2004.Objective: To determine whether national ART scale-up was associated with annual national TB case notification rates (CNR), strati...
Saved in:
| Published in: | Public health action 2016-09, Vol.6 (3), p.164-168 |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c440t-b3edcbe31a0f11f4e828e5473bf9403d5e0ec1e61ba9edd76189f91bca8049f93 |
|---|---|
| cites | |
| container_end_page | 168 |
| container_issue | 3 |
| container_start_page | 164 |
| container_title | Public health action |
| container_volume | 6 |
| creator | Takarinda, K. C. Harries, A. D. Sandy, C. Mutasa-Apollo, T. Zishiri, C. |
| description | Setting: Zimbabwe has a human immunodeficiency virus (HIV) driven tuberculosis (TB) epidemic, with antiretroviral therapy (ART) scaled up in the public sector since 2004.Objective: To determine whether national ART scale-up was associated with annual national TB case
notification rates (CNR), stratified by disease type and category, between 2000 and 2013.Design: This was a retrospective study using aggregate data from global reports.Results: The number of people living with HIV and retained on ART from 2004 to 2013 increased from
8400 to 665 299, with ART coverage increasing from |
| doi_str_mv | 10.5588/pha.16.0029 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_5588_pha_16_0029</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><ingid>iuatld/pha/2016/00000006/00000003/art00003</ingid><sourcerecordid>1835363427</sourcerecordid><originalsourceid>FETCH-LOGICAL-c440t-b3edcbe31a0f11f4e828e5473bf9403d5e0ec1e61ba9edd76189f91bca8049f93</originalsourceid><addsrcrecordid>eNpVkUtrHDEQhIeQEBvHp9yDjoEwGz3mobkEEjt2DAZfnEsuoqVpeWVmpYmksfG_j3bXWey-qKA_SkVXVX1kdNW2Un6d17Bi3YpSPrypjjnntJai529f6KPqNKV7WqajnEn-vjrifTe0XS-PK3uOZnLe-TuSF43RLFNILhEDCYkP2VlnILvgSYSMiTy6vCZ5jSQZmLBeZhIsAZ9dxBzDg4swbdcR5ifiPPnjNhr0I36o3lmYEp4-vyfV74uft2e_6uuby6uz79e1aRqaay1wNBoFA2oZsw1KLrFteqHt0FAxtkjRMOyYhgHHse-YHOzAtAFJm6LESfVt7zsvelO80OeSSM3RbSA-qQBOvd54t1Z34UG1VDS9ZMXg87NBDH8XTFltXDI4TeAxLEkxKVrRiYb3Bf2yR00MKUW0h28YVdtyVClHsU5tyyn0p5fJDuz_KgrwYw-ULko4UPdhib4cS7kF8jTu3Djd-e3mIISCmHdC_AMxT6Lx</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1835363427</pqid></control><display><type>article</type><title>Declining tuberculosis case notification rates with the scale-up of antiretroviral therapy in Zimbabwe</title><source>IngentaConnect Journals</source><source>PubMed Central</source><creator>Takarinda, K. C. ; Harries, A. D. ; Sandy, C. ; Mutasa-Apollo, T. ; Zishiri, C.</creator><creatorcontrib>Takarinda, K. C. ; Harries, A. D. ; Sandy, C. ; Mutasa-Apollo, T. ; Zishiri, C.</creatorcontrib><description>Setting: Zimbabwe has a human immunodeficiency virus (HIV) driven tuberculosis (TB) epidemic, with antiretroviral therapy (ART) scaled up in the public sector since 2004.Objective: To determine whether national ART scale-up was associated with annual national TB case
notification rates (CNR), stratified by disease type and category, between 2000 and 2013.Design: This was a retrospective study using aggregate data from global reports.Results: The number of people living with HIV and retained on ART from 2004 to 2013 increased from
8400 to 665 299, with ART coverage increasing from <0.5% to 48%. TB CNRs, all types and categories, increased from 2000 to 2003, and declined thereafter from 2004 to 2013. The decreases in annual TB notifications between the highest rates (before 2004) and lowest rates (2013) were all forms
of TB (56%), new TB (60%), previously treated TB (53%), new smear-positive pulmonary TB (PTB) (40%), new smear-negative/smear-unknown PTB (58%) and extra-pulmonary TB (58%).Conclusion: Significant declines in TB CNRs were observed during ART scale-up, especially for smear-negative
PTB and extra-pulmonary TB. These encouraging national trends support the continued scale-up of ART for people living with HIV as a way of tackling the twin epidemics of HIV/acquired immune-deficiency syndrome and TB in Zimbabwe.</description><identifier>ISSN: 2220-8372</identifier><identifier>EISSN: 2220-8372</identifier><identifier>DOI: 10.5588/pha.16.0029</identifier><identifier>PMID: 27695678</identifier><language>eng</language><publisher>France: International Union Against Tuberculosis and Lung Disease</publisher><subject>HIV/AIDS ; Operational Research ; Original ; Recurrent Tb ; Tuberculosis ; Zimbabwe</subject><ispartof>Public health action, 2016-09, Vol.6 (3), p.164-168</ispartof><rights>2016 The Union 2016</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c440t-b3edcbe31a0f11f4e828e5473bf9403d5e0ec1e61ba9edd76189f91bca8049f93</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034781/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034781/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,315,730,783,787,888,27936,27937,53763,53804,53806</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27695678$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Takarinda, K. C.</creatorcontrib><creatorcontrib>Harries, A. D.</creatorcontrib><creatorcontrib>Sandy, C.</creatorcontrib><creatorcontrib>Mutasa-Apollo, T.</creatorcontrib><creatorcontrib>Zishiri, C.</creatorcontrib><title>Declining tuberculosis case notification rates with the scale-up of antiretroviral therapy in Zimbabwe</title><title>Public health action</title><addtitle>Public Health Action</addtitle><description>Setting: Zimbabwe has a human immunodeficiency virus (HIV) driven tuberculosis (TB) epidemic, with antiretroviral therapy (ART) scaled up in the public sector since 2004.Objective: To determine whether national ART scale-up was associated with annual national TB case
notification rates (CNR), stratified by disease type and category, between 2000 and 2013.Design: This was a retrospective study using aggregate data from global reports.Results: The number of people living with HIV and retained on ART from 2004 to 2013 increased from
8400 to 665 299, with ART coverage increasing from <0.5% to 48%. TB CNRs, all types and categories, increased from 2000 to 2003, and declined thereafter from 2004 to 2013. The decreases in annual TB notifications between the highest rates (before 2004) and lowest rates (2013) were all forms
of TB (56%), new TB (60%), previously treated TB (53%), new smear-positive pulmonary TB (PTB) (40%), new smear-negative/smear-unknown PTB (58%) and extra-pulmonary TB (58%).Conclusion: Significant declines in TB CNRs were observed during ART scale-up, especially for smear-negative
PTB and extra-pulmonary TB. These encouraging national trends support the continued scale-up of ART for people living with HIV as a way of tackling the twin epidemics of HIV/acquired immune-deficiency syndrome and TB in Zimbabwe.</description><subject>HIV/AIDS</subject><subject>Operational Research</subject><subject>Original</subject><subject>Recurrent Tb</subject><subject>Tuberculosis</subject><subject>Zimbabwe</subject><issn>2220-8372</issn><issn>2220-8372</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNpVkUtrHDEQhIeQEBvHp9yDjoEwGz3mobkEEjt2DAZfnEsuoqVpeWVmpYmksfG_j3bXWey-qKA_SkVXVX1kdNW2Un6d17Bi3YpSPrypjjnntJai529f6KPqNKV7WqajnEn-vjrifTe0XS-PK3uOZnLe-TuSF43RLFNILhEDCYkP2VlnILvgSYSMiTy6vCZ5jSQZmLBeZhIsAZ9dxBzDg4swbdcR5ifiPPnjNhr0I36o3lmYEp4-vyfV74uft2e_6uuby6uz79e1aRqaay1wNBoFA2oZsw1KLrFteqHt0FAxtkjRMOyYhgHHse-YHOzAtAFJm6LESfVt7zsvelO80OeSSM3RbSA-qQBOvd54t1Z34UG1VDS9ZMXg87NBDH8XTFltXDI4TeAxLEkxKVrRiYb3Bf2yR00MKUW0h28YVdtyVClHsU5tyyn0p5fJDuz_KgrwYw-ULko4UPdhib4cS7kF8jTu3Djd-e3mIISCmHdC_AMxT6Lx</recordid><startdate>20160921</startdate><enddate>20160921</enddate><creator>Takarinda, K. C.</creator><creator>Harries, A. D.</creator><creator>Sandy, C.</creator><creator>Mutasa-Apollo, T.</creator><creator>Zishiri, C.</creator><general>International Union Against Tuberculosis and Lung Disease</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20160921</creationdate><title>Declining tuberculosis case notification rates with the scale-up of antiretroviral therapy in Zimbabwe</title><author>Takarinda, K. C. ; Harries, A. D. ; Sandy, C. ; Mutasa-Apollo, T. ; Zishiri, C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c440t-b3edcbe31a0f11f4e828e5473bf9403d5e0ec1e61ba9edd76189f91bca8049f93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>HIV/AIDS</topic><topic>Operational Research</topic><topic>Original</topic><topic>Recurrent Tb</topic><topic>Tuberculosis</topic><topic>Zimbabwe</topic><toplevel>online_resources</toplevel><creatorcontrib>Takarinda, K. C.</creatorcontrib><creatorcontrib>Harries, A. D.</creatorcontrib><creatorcontrib>Sandy, C.</creatorcontrib><creatorcontrib>Mutasa-Apollo, T.</creatorcontrib><creatorcontrib>Zishiri, C.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Public health action</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Takarinda, K. C.</au><au>Harries, A. D.</au><au>Sandy, C.</au><au>Mutasa-Apollo, T.</au><au>Zishiri, C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Declining tuberculosis case notification rates with the scale-up of antiretroviral therapy in Zimbabwe</atitle><jtitle>Public health action</jtitle><addtitle>Public Health Action</addtitle><date>2016-09-21</date><risdate>2016</risdate><volume>6</volume><issue>3</issue><spage>164</spage><epage>168</epage><pages>164-168</pages><issn>2220-8372</issn><eissn>2220-8372</eissn><abstract>Setting: Zimbabwe has a human immunodeficiency virus (HIV) driven tuberculosis (TB) epidemic, with antiretroviral therapy (ART) scaled up in the public sector since 2004.Objective: To determine whether national ART scale-up was associated with annual national TB case
notification rates (CNR), stratified by disease type and category, between 2000 and 2013.Design: This was a retrospective study using aggregate data from global reports.Results: The number of people living with HIV and retained on ART from 2004 to 2013 increased from
8400 to 665 299, with ART coverage increasing from <0.5% to 48%. TB CNRs, all types and categories, increased from 2000 to 2003, and declined thereafter from 2004 to 2013. The decreases in annual TB notifications between the highest rates (before 2004) and lowest rates (2013) were all forms
of TB (56%), new TB (60%), previously treated TB (53%), new smear-positive pulmonary TB (PTB) (40%), new smear-negative/smear-unknown PTB (58%) and extra-pulmonary TB (58%).Conclusion: Significant declines in TB CNRs were observed during ART scale-up, especially for smear-negative
PTB and extra-pulmonary TB. These encouraging national trends support the continued scale-up of ART for people living with HIV as a way of tackling the twin epidemics of HIV/acquired immune-deficiency syndrome and TB in Zimbabwe.</abstract><cop>France</cop><pub>International Union Against Tuberculosis and Lung Disease</pub><pmid>27695678</pmid><doi>10.5588/pha.16.0029</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2220-8372 |
| ispartof | Public health action, 2016-09, Vol.6 (3), p.164-168 |
| issn | 2220-8372 2220-8372 |
| language | eng |
| recordid | cdi_crossref_primary_10_5588_pha_16_0029 |
| source | IngentaConnect Journals; PubMed Central |
| subjects | HIV/AIDS Operational Research Original Recurrent Tb Tuberculosis Zimbabwe |
| title | Declining tuberculosis case notification rates with the scale-up of antiretroviral therapy in Zimbabwe |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-11-13T13%3A55%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Declining%20tuberculosis%20case%20notification%20rates%20with%20the%20scale-up%20of%20antiretroviral%20therapy%20in%20Zimbabwe&rft.jtitle=Public%20health%20action&rft.au=Takarinda,%20K.%20C.&rft.date=2016-09-21&rft.volume=6&rft.issue=3&rft.spage=164&rft.epage=168&rft.pages=164-168&rft.issn=2220-8372&rft.eissn=2220-8372&rft_id=info:doi/10.5588/pha.16.0029&rft_dat=%3Cproquest_cross%3E1835363427%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c440t-b3edcbe31a0f11f4e828e5473bf9403d5e0ec1e61ba9edd76189f91bca8049f93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1835363427&rft_id=info:pmid/27695678&rft_ingid=iuatld/pha/2016/00000006/00000003/art00003&rfr_iscdi=true |